Pregled bibliografske jedinice broj: 997868
High-performance liquid chromatography for HbA1c in low-volume laboratories: analytical verification and method comparison study of Tosoh HLC-723GX analyzer
High-performance liquid chromatography for HbA1c in low-volume laboratories: analytical verification and method comparison study of Tosoh HLC-723GX analyzer // The 4th Joint EFLM-UEMS Congress “Laboratory Medicine at the Clinical Interface” / Plebani, Mario (ur.).
Berlin: Walter de Gruyter, 2016. str. eA362-eA362 doi:10.1515/cclm-2016-0657 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 997868 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
High-performance liquid chromatography for HbA1c in low-volume laboratories: analytical verification and method comparison study of Tosoh HLC-723GX analyzer
Autori
Ris, Marko ; Radišić Biljak, Vanja ; Božičević, Sandra ; Vučić Lovrenčić, Marijana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
The 4th Joint EFLM-UEMS Congress “Laboratory Medicine at the Clinical Interface”
Mjesto i datum
Varšava, Poljska, 21.09.2016. - 24.09.2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
HPLC, HbA1c, verification
Sažetak
Introduction: High-performance liquid chromatography (HPLC) determination of HbA1c has long been used as a reproducible and versatile analytical tool in clinical laboratories. However, the need for dedicated equipment and expertise limited its use to high-volume laboratories. Recently introduced user-friendly, fully automated benchtop HPLC analyzer (Tosoh HLC-723GX, Tosoh, Japan) enabled low-volume laboratories to provide equally reliable HbA1c results. The aim of this study was to perform analytical verification of Tosoh HLC-723GX analyzer and compare the results with both the reference capillary electrophoresis (CE) and the immunoassay (IA) procedure. Materials and Methods: The total imprecision of Tosoh HLC-723GX was verified in accordance with CLSI EP15-A2 protocol using commercial control materials (C-QC) and pooled human whole blood samples (HWB). Comparison of HbA1c results was performed on 146 samples (3.214.4%/ 12-134 mmol/mol). HPLC-HbA1c results were compared to the automated CE (CE ; MiniCap Flex Piercing, Sebia, France) and IA (IA ; Tina-quant HbA1c Gen 2, Cobas Integra 400+, Roche Diagnostics, USA) procedures, respectively. Results: The total imprecision of HPLC-HbA1c was 1.25/1.91% (HbA1c = 4.8%/29 mmol/mol) and 0.51/0.63% (HbA1c = 97%/82mmol/mol) in C-QC, and 0.51/0.66% (HbA1c = 6.5%/47mmol/mol) and 0.65/0.87% (HbA1c = 10.7%/94 mmol/mol) in HWB samples, respectively. Bland-Altman analysis did not reveal any deviation of the results between HPLC and CE: 0.0% (95%Cl: -0.02927 to 0.02653%), while the average HbA1c deviation between HPLC and IA was -0.07% (95%Cl: -0.1039 to -0.02765). Conclusion: The performance of Tosoh HLC-723GX met the quality criteria for reliable clinical use, thereby representing a plausible analytical choice for HbA1c measurement in low-volume laboratories.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE